Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Am Heart J. 2006 Jul; 152(1):157-63.

View in: PubMed

subject areas

Aged
Angioplasty, Balloon, Coronary
Antithrombins
Coronary Disease
Drug Therapy, Combination
Female
Heparin
Hirudins
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Peptide Fragments
Platelet Glycoprotein GPIIb-IIIa Complex
Randomized Controlled Trials as Topic
Recombinant Proteins
Risk Factors
Stroke Volume
Treatment Outcome

authors with profiles

Robert Harrington